Shattuck Labs, Inc. (STTK) income statement
STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$4.59−0.07 (-1.50%)
Close on Nov 17, 2026Market cap $460.67MP/E –Yield –
Shattuck Labs, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -5578.7%
- Net margin
- -5256.8%
- Return on equity, FY2025
- -60.3%
Financial strength
- Current ratio
- 27.59
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 818.8%
Valuation
- P/E ratio
- –
- Price to sales
- 460.67
- Price to book
- 2.18
- Dividend yield
- –
See a number that looks wrong?